This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrough so advanced, it’s going to make ChatGPT look like VHS. But what’s even more unbelievable? I believe it’ll make Nvidia’s meteoric rise look like a backyard bottle rocket.

Click here and I’ll tell you everything you need to know.

Silvana Battaglia net worth and biography

Silvana Battaglia Biography and Net Worth

EVP of Cencora

Silvana Battaglia is Executive Vice President and Chief Human Resources Officer for AmerisourceBergen Corporation. Ms. Battaglia brings more than two decades of experience running both domestic and international human resources organizations, shaping high-performance cultures and driving organizational effectiveness within the pharmaceutical and business services sectors. Prior to being named to her current role in January 2019, Ms. Battaglia was Senior Vice President of Global Compensation, Benefits and Labor Relations at Aramark, where she led the Total Rewards strategy, design and development of HR policies and processes and the company’s labor strategy. At Aramark, she also served as Senior Vice President, Global Field Human Resources and had direct responsibility for the delivery and deployment of strategic HR practices for more than 270,000 associates worldwide located across 22 countries. Prior to these roles, Ms. Battaglia held executive human resources leadership roles at both Day & Zimmerman and Merck, and gained early HR experience at Wyeth Pharmaceuticals and Colorcon, a Division of Berwind Pharmaceuticals. She has also served as an adjunct faculty member at St. Joseph's University in Philadelphia.

Ms. Battaglia graduated from Temple University with a Bachelor of Arts in Marketing and received her Masters of Science in Human Resources from Widener University.

What is Silvana Battaglia's net worth?: The estimated net worth of Silvana Battaglia is at least $2.75 million as of August 6th, 2024. Ms. Battaglia owns 10,948 shares of Cencora stock worth more than $2,746,963 as of December 3rd. This net worth estimate does not reflect any other assets that Ms. Battaglia may own. Additionally, Ms. Battaglia receives a salary of $1,580,000.00 as EVP at Cencora. Learn More about Silvana Battaglia's net worth.
How old is Silvana Battaglia?: Ms. Battaglia is currently 56 years old. There are 7 older executives and no younger executives at Cencora. The oldest executive at Cencora is Ms. Gina K. Clark, Executive VP and Chief Communications & Administration Officer, who is 67 years old. Learn More on Silvana Battaglia's age.
What is Silvana Battaglia's salary?: As the EVP of Cencora, Inc., Ms. Battaglia earns $1,580,000.00 per year. There are 4 executives that earn more than Ms. Battaglia. The highest earning executive at Cencora is Mr. Steven H. Collis, Chairman, President & CEO, who commands a salary of $5,010,000.00 per year. Learn More on Silvana Battaglia's salary.
How do I contact Silvana Battaglia?: The corporate mailing address for Ms. Battaglia and other Cencora executives is 1300 MORRIS DRIVE, CHESTERBROOK PA, 19087. Cencora can also be reached via phone at (610) 727-7000 and via email at [email protected]. Learn More on Silvana Battaglia's contact information.
Has Silvana Battaglia been buying or selling shares of Cencora?: Silvana Battaglia has not been actively trading shares of Cencora during the last ninety days. Most recently, Silvana Battaglia sold 1,473 shares of the business's stock in a transaction on Tuesday, August 6th. The shares were sold at an average price of $242.69, for a transaction totalling $357,482.37. Following the completion of the sale, the executive vice president now directly owns 10,948 shares of the company's stock, valued at $2,656,970.12. Learn More on Silvana Battaglia's trading history.
Who are Cencora's active insiders?: Cencora's insider roster includes Silvana Battaglia (EVP), Elizabeth Campbell (EVP), John Chou (EVP), Gina Clark (EVP), Gina Clark (EVP), Steven Collis (CEO), Leslie Donato (EVP), Leslie Donato (EVP), Jeffrey Finnin (CFO), Juan Font (SVP), Jane Henney, MD (Director), Mark Jones (CAO), Maile Kaiser (SVP), Michael Koehler (Director), Lazarus Krikorian (CAO), Aleksandra Krusko (SVP), Robert Mauch (EVP), Robert Mauch (COO), Derek McCandless (SVP), Henry McGee, III (Director), Steven Smith (CRO), Paul Szurek (CEO), and Brian Warren (SVP). Learn More on Cencora's active insiders.
Are insiders buying or selling shares of Cencora?: During the last year, Cencora insiders bought shares 1 times. They purchased a total of 500 shares worth more than $109,290.00. During the last year, insiders at the sold shares 16 times. They sold a total of 10,748,964 shares worth more than $2,514,519,586.19. The most recent insider tranaction occured on November, 25th when Chairman Steven H Collis sold 50,000 shares worth more than $12,198,500.00. Insiders at Cencora own 15.8% of the company. Learn More about insider trades at Cencora.
Information on this page was last updated on 11/25/2024.

Silvana Battaglia Insider Trading History at Cencora

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/6/2024	Sell	1,473	$242.69	$357,482.37	10,948
3/15/2022	Sell	6,820	$149.96	$1,022,727.20
8/6/2021	Sell	4,655	$121.95	$567,677.25	5,020

Silvana Battaglia Buying and Selling Activity at Cencora

Cencora Company Overview

Cencora, Inc. sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe; and provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

Today's Range

Now: $250.91

$249.83

$252.40

50 Day Range

MA: $235.35

$219.50

$251.60

2 Week Range

Now: $250.91

$195.83

$253.27

Volume

267,536 shs

Average Volume

1,388,443 shs

Market Capitalization

$49.44 billion

P/E Ratio

33.41

Dividend Yield

0.87%

Beta

0.45

Missed Nvidia? Watch this ASAP

From Brownstone Research | Ad

Click here and I’ll tell you everything you need to know.

Silvana Battaglia Biography and Net Worth

What is Silvana Battaglia's net worth?

How old is Silvana Battaglia?

What is Silvana Battaglia's salary?

How do I contact Silvana Battaglia?

Has Silvana Battaglia been buying or selling shares of Cencora?

Who are Cencora's active insiders?

Are insiders buying or selling shares of Cencora?